Hengdao Liu
Overview
Explore the profile of Hengdao Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Huo J, Ren K, Pan S, Liu H, Zheng Y, et al.
Cell Death Discov
. 2024 Mar;
10(1):148.
PMID: 38509100
Diabetic cardiomyopathy (DCM), an important complication of diabetes mellitus (DM), is one of the most serious chronic heart diseases and has become a major cause of heart failure worldwide. At...
2.
Dao L, Liu H, Xiu R, Yao T, Tong R, Xu L
Phytomedicine
. 2024 Jan;
125:155325.
PMID: 38295663
Background: Sepsis and its associated heart failure are among the leading causes of death. Gramine, a natural indole alkaloid, can be extracted from a wide variety of raw plants, and...
3.
Luan Y, Yang Y, Luan Y, Liu H, Xing H, Pei J, et al.
J Zhejiang Univ Sci B
. 2024 Jan;
25(1):1-22.
PMID: 38163663
Cardiovascular diseases (CVDs) are a leading factor driving mortality worldwide. Iron, an essential trace mineral, is important in numerous biological processes, and its role in CVDs has raised broad discussion...
4.
Li J, Lu H, Chen S, Xiang H, Liu H, Zhao S
Zhong Nan Da Xue Xue Bao Yi Xue Ban
. 2022 Nov;
47(9):1171-1181.
PMID: 36411700
Objectives: Trimethylamine oxide (TMAO) is a metabolite of intestinal flora and is known to promote the progression of atherosclerotic plaques. However, how TMAO works, including its effect on vascular endothelial...
5.
Liu H, Zhao Y, Lu Y, Zhou S, Zhang Y, Zhao J, et al.
Clin Appl Thromb Hemost
. 2022 Aug;
28:10760296221118489.
PMID: 35945818
The study aimed to evaluate the efficacy and safety of drug coated balloon-only strategy (DCB-only) in the treatment of de novo left main coronary artery (LM) bifurcation lesions. 85 patients...
6.
Liu Y, Xiang H, Xiong W, OuYang J, Liu H, Zhao S, et al.
Diab Vasc Dis Res
. 2022 May;
19(3):14791641221102513.
PMID: 35549572
Objectives: This study aims to determine the role and mechanism of autophagy in endothelial cell dysfunction by glucolipotoxicity. Methods: Human umbilical vein endothelial cells (HUVECs) were treated with high glucose...
7.
Wang H, Liu H, Zhao X, Chen X
Bioengineered
. 2022 May;
13(5):11469-11486.
PMID: 35535400
Coronary artery disease (CAD) represents a fatal public threat. The involvement of extracellular vesicles (EVs) in CAD has been documented. This study explored the regulation of embryonic stem cells (ESCs)-derived...
8.
Liu H, Tao H, Han X, Lu Y, Xue X, Feng R, et al.
J Interv Cardiol
. 2022 Jan;
2022:8250057.
PMID: 35095348
Background: Drug-eluting stent (DES) plus drug-coated balloon (DCB) is a safe and effective treatment strategy for coronary artery bifurcation lesions, but there is no report about this strategy being used...
9.
Chen X, Zhao J, Zhu K, Qin F, Liu H, Tao H
Front Cardiovasc Med
. 2021 Dec;
8:756552.
PMID: 34869668
The connection between revascularization for coronary artery disease (CAD) and the incidence of recurrent events of atrial fibrillation (AF) after ablation is unclear. This study aimed to explore the relationship...
10.
Ouyang M, Qin T, Liu H, Lu J, Peng C, Guo Q
Exp Clin Endocrinol Diabetes
. 2020 Mar;
129(5):339-348.
PMID: 32176932
Objective: High-fat diet (HFD) increases the risk of inflammatory reaction and acute arterial thrombosis. Celastrol has been confirmed to regulate inflammatory cytokine levels in atherosclerotic animal models. However, the anti-thrombotic...